The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2010
DOI: 10.1039/c0jm00805b
|View full text |Cite
|
Sign up to set email alerts
|

Multimodal biomaterial strategies for regeneration of infarcted myocardium

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
22
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 24 publications
(22 citation statements)
references
References 207 publications
(183 reference statements)
0
22
0
Order By: Relevance
“…Candidate substrate materials must exhibit biocompatibility, while supporting cell proliferation, which is hypothesized to be a direct function of its stiffness. Bioengineered scaffold stiffness must be closely resemble that of native ECM and flexible to allow the contraction of growing cells . In the case of PCL membranes, 3T3 fibroblast cell proliferation was most significant on low stiffness samples .…”
Section: Introductionmentioning
confidence: 99%
“…Candidate substrate materials must exhibit biocompatibility, while supporting cell proliferation, which is hypothesized to be a direct function of its stiffness. Bioengineered scaffold stiffness must be closely resemble that of native ECM and flexible to allow the contraction of growing cells . In the case of PCL membranes, 3T3 fibroblast cell proliferation was most significant on low stiffness samples .…”
Section: Introductionmentioning
confidence: 99%
“…They should (1) have compliant mechanical properties with native tissue, (2) be biodegradable, (3) have a pore size and interconnectivity favorable to the establishment of vascular networks, colonization by cardiomyocytes or progenitors, and facilitate oxygen and nutrients diffusion, (4) promote cellular adhesion (e.g., peptide sequence RGD in hydrogels), and (5) allow the incorporation of bioactive molecules to be released with specific kinetics. Examples of materials already tested in MI therapy include natural (e.g., collagen, fibrin, hyaluronan, alginate) or synthetic (e.g., polyethylene glycol (PEG) hydrogels; poly (glycerol sebacate), polyester urethane urea elastomers) materials [78]. These biomaterials can be envisioned as the first generation biomaterials for cardiac tissue engineering (Fig.…”
Section: Biomaterials As Sensors and Effectors At The Cardiac Environmentioning
confidence: 99%
“…The myocardial tissue has poor capability to regenerate itself. Consequently, infarcted area is replaced by fibrous scar tissue (Castilho et al, ; Mukherjee, Venugopal, Ravichandran, Ramakrishna, & Raghunath, ). Owing to shortage of heart donors, it is necessary to develop new approaches for regeneration of the injured myocardium.…”
Section: Introductionmentioning
confidence: 99%